A Case of Euglycemic Diabetic Ketoacidosis due to Empagliflozin Use in a Patient with Type 1 Diabetes Mellitus
Euglycemic diabetic ketoacidosis is characterised by serum blood glucose <250 mg/dl, arterial blood pH <7.35, and the presence of ketones in urine or blood. Here, we present a 36-year female with type-1 diabetes mellitus, a case of euglycemic diabetic ketoacidosis, who was admitted to the emer...
Main Authors: | Aktas, G. (Author), Bilgin, S. (Author), Duman, T.T (Author), Kurtkulagi, O. (Author), Yilmaz, F. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
NLM (Medline)
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Euglycemic Diabetic Ketoacidosis in a Lung Cancer Patient Using Empagliflozin
by: Jordan Sexe, et al.
Published: (2020-01-01) -
Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis
by: Marta Brandão Calçada, et al.
Published: (2021-04-01) -
Euglycemic Diabetic Ketoacidosis in Pregnancy
by: Júlio César Garcia de Alencar, et al.
Published: (2020-02-01) -
Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review
by: Erasmia Sampani, et al.
Published: (2020-07-01) -
Euglycemic diabetic ketoacidosis associated with uremia
by: Mingxia Zhang, et al.
Published: (2021-02-01)